Several molecular targets such as cyclooxygenase [27] and potassium channels [28], metabolism pathways such as triacylglycerol synthesis pathway [29,30,31] and pro-angiogenic properties [32] have also been identified to explain the potential role of chalcones in the prevention and/or treatment of cardiovascular diseases. Here, KCNA3 is linked to cardiovascular disorder.